How to Recruit Subjects and Enlist Sponsors for Clinical Trials

Oct 30, 2012, 15:22 ET from Global Information, Inc.

FARMINGTON, Conn., Oct. 30, 2012 /PRNewswire-iReach/ -- Global Information Inc (GII) offers the latest in clinical trials research from our premium research partner, GlobalData. These market research reports provide essential data relating to clinical trials for disease, treatment and symptoms. Each report includes an overview of the trial numbers and their recruitment status; preliminary coverage of clinical trials by phase; trial status; and prominence of sponsors for segment-specific clinical trials.


In addition to these excellent new reports, GII can provide readers with briefs, summaries, and full access to over 650 clinical trial reviews. To view a full list of our clinical trial reviews, please visit:

Hyponatremia Global Clinical Trials Review, H2, 2012

Individuals with suffering from a metabolic condition called hyponatremia do not have enough salt in the body fluids outside their body's cells; it's a common disorder related to electrolytes. GlobalData's hyponatremia clinical trials review provides detailed figures and tables that help executives understand the dynamics shaping the future of this market.

The scope of this report includes data on the number of clinical trials by geographic region; complete and in-progress clinical trial data by phase, trial status, subjects recruited and sponsor type; and a list of discontinued trials.

An Executive Summary for this report and free sample pages from the full document are available at

Chemotherapy Induced Nausea and Vomiting Global Clinical Trials Review, H2, 2012

Understand the dynamics of the global clinical trials market for chemotherapy induced nausea and vomiting. This report presents an abridged view of the performance of clinical trials in this segment in terms of their status, recruitment, location, sponsor type and many more.

An Executive Summary for this report and free sample pages from the full document are available at

Pulmonary Embolism Global Clinical Trials Review, H2, 2012

Pulmonary embolism affects billions. Sitting for long hours and a general lack of mobility elevates an individual's risk. This report profiles the top five countries contributing to clinical trials in the pulmonary embolism (PE) field. Top companies participating in PE therapeutics clinical trials are also discussed including: Bristol-Myers Squibb, GlaxoSmithKline, Bayer AG, Sanofi, AGEN Biomedical Limited, EKOS, Pfizer, Rovi, Eisai Inc., and more.

An Executive Summary for this report and free sample pages from the full document are available at

About Global Information Inc. Global Information (GII) ( is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.

Media Contact: Jeremy Palaia of Global Information, Inc., 1-860-674-8796, 

News distributed by PR Newswire iReach:

SOURCE Global Information, Inc.